Botanical species · safety record

Schinus terebinthifolia

The EFSA Compendium of Botanicals holds 6 constituent measurements and 1 adverse-effect record for Schinus terebinthifolia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Schinus terebinthifolia Raddi

6Constituent measurements
1Safety records
5Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Tannins3
  • Myrcene2
  • Eugenol1

Plant parts

  • Fruit unspecified4
  • Leaves2
  • Bark1

Preparations

  • Essential oil3
  • Solvent extraction3

Effect types

  • Pulmonary and cardiac1

Target tissues

  • Digestive1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
TanninsLeavesSolvent extraction≤ 10.3 PercentPhytochemical screeningResolve DOI
TanninsLeavesSolvent extraction≥ 7.5 PercentPhytochemical screeningResolve DOI
TanninsBarkSolvent extraction124.1 Milligram/gramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
EugenolFruit unspecifiedEssential oil1.71 PercentGC-MSNo resolvable identifier
MyrceneFruit unspecifiedEssential oil1.99 PercentGC-MSNo resolvable identifier
MyrceneFruit unspecifiedEssential oil1.89 PercentGC-MSNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
Pulmonary and cardiacDigestiveFruit unspecifiedHuman (as organism)Not reportedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Tucker, AO., Maciarello, MJ., Contis, ET., Ho, CT., Mussinan, CJ., Parliment, TH., Shahidi, F., Spanier, AM. Some toxic culinary herbs in North America. Food flavors: formation, analysis, and packaging influences, 1998, vol. 40, p. 401-414.
  2. Silva Ary G., Almeida Drielle L., Ronchi Silas N., Bento Amarildo C., Scherer Rodrigo., Ramos Alessandro C., Cruz Zilma Ma. The essential oil of Brazilian pepper, Schinus terebinthifolia Raddi in larval control of Stegomyia aegypti (Linnaeus, 1762). Parasites & vectors, 2010, vol. 3, p. 79.
  3. Marino, Daniele Cestari., Lacerda Sabino, Larissa Zuppardo., Armando, Jose, Jr., Ruggiero, Andrea De Andrade., Moya, Horacio Dorigan. Analysis of the Polyphenols Content in Medicinal Plants Based on the Reduction of Cu(II)/Bicinchoninic Complexes . Journal of agricultural and food chemistry, 2009, vol. 57, no. 23, p. 11061-11066. DOI
  4. Nocchi, Samara Requena., Pereira Companhoni, Mychelle Vianna., Palazzo de Mello, Joao Carlos., Dias Filho, Benedito Prado., Nakamura, Celso Vataru., Carollo, Carlos Alexandre., Silva, Denise Brentan., Ueda-Nakamura, Tnia. Antiviral Activity of Crude Hydroethanolic Extract from Schinus terebinthifolia against Herpes simplex Virus Type 1 . Planta medica, 2017, vol. 83, no. 6, p. 509-518. DOI
  5. Pratti Drielle L A., Ramos Alessandro C., Scherer Rodrigo., Pratti Drielle L A., Ramos Alessandro C., Cruz Zilma M A., Silva Ary G., Scherer Rodrigo., Silva Ary G. Mechanistic basis for morphological damage induced by essential oil from Brazilian pepper tree, Schinus terebinthifolia, on larvae of Stegomyia aegypti, the dengue vector. Parasites & vectors, 2015, vol. 8, p. 136.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue